Aptus Pharma Ltd 52 Week Low
Aptus Pharma Ltd
NSE: APPL
YEARLOW
Key Highlights
- The 52 Week Low of Aptus Pharma Ltd is ₹ 80.8 as of 01 Apr 26 .
Company Fundamentals for Aptus Pharma Ltd
Market Price of Aptus Pharma Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 01 Apr 2026 | 345.05 |
| 30 Mar 2026 | 349.15 |
| 27 Mar 2026 | 356.25 |
| 25 Mar 2026 | 349.3 |
| 24 Mar 2026 | 342.55 |
| 23 Mar 2026 | 335.85 |
| 20 Mar 2026 | 329.3 |
| 18 Mar 2026 | 322.85 |
| 17 Mar 2026 | 329.4 |
| 16 Mar 2026 | 346.7 |
Asset Value vs Market Value of Aptus Pharma Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Aptus Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Aptus Pharma Ltd
Historical Net Profit of Aptus Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Aptus Pharma Ltd
Aptus Pharma Ltd News Hub
Shares of Aptus Pharma list in MT Group
The equity shares of Aptus Pharma (Scrip Code: 544529) are listed effective 30 September 2025 and ad
Read more
30 Sept 25
BSE SME Aptus Pharma cures listing-day jitters with premium opening
The scrip was listed at Rs 80.80, a premium of 15.43% over the initial public offer (IPO) price. The
Read more
30 Sept 25
Aptus Pharma schedules board meeting
Aptus Pharma will hold a meeting of the Board of Directors of the Company on 10 November 2025. Power
Read more
03 Nov 25
Aptus Pharma jumps 24% in six days
Shares of Aptus Pharma surged 23.89% in ten trading sessions from its recent closing low of Rs 169.5
Read more
08 Jan 26
